VALYSTR · Stock research
Listed on NYSE. What the market is pricing into ResMed Inc. (RMD) in the Healthcare sector: implied growth, valuation scenarios, SEC-filed financials, and what has moved the stock.
Healthcare · Medical Specialties · market value about $32.8B · P/E 20.7 · revenue $5.7B (as of 2026-11-04)
Opening the full page… All companies · Research guides · What a reverse DCF shows